今海醫療科技(02225.HK)攜手戴維醫療共拓全球內窺鏡市場
格隆匯7月2日丨今海醫療科技(02225.HK)發佈公告,2025年7月2日,公司的全資附屬公司上海今海醫療科技有限公司(“上海今海”)與戴維醫療(300314.SZ)的全資附屬公司寧波維爾凱迪醫療器械有限公司(“維爾凱迪醫療”)訂立爲期五年的合作框架協議。
根據該協議,上海今海與戴維醫療集團將致力於在國際市場上開展內窺鏡產品的聯合合作,旨在打造在國際市場上具有競爭力的高端醫療器械解決方案。內窺鏡產品將爲雙方建立長期合作關係奠定基礎。預期當合作有進展時,維爾凱迪醫療將擁有集團硬性內窺鏡產品的獨家優先權及獨家海外分銷權。上海今海與戴維醫療集團將利用各自在內窺鏡產品生產和銷售方面的比較優勢,積極開拓海外市場,並通過優化資源配置、供應鏈協同和產能聯動,提升產品交付效率和成本競爭力。
上海今海亦將與維爾凱迪醫療合作,推動內窺鏡產品在各國註冊及申請國際認證,加速內窺鏡產品的國際化進程,並在多個研究中心開展臨牀研究,建立國際學術交流平臺,通過醫學教育、技術培訓、聯合品牌推廣等方式,增強內窺鏡產品的全球學術影響力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.